Literature DB >> 34300048

Heart Metabolism in Sepsis-Induced Cardiomyopathy-Unusual Metabolic Dysfunction of the Heart.

Weronika Wasyluk1,2, Patrycja Nowicka-Stążka1, Agnieszka Zwolak1.   

Abstract

Due to the need for continuous work, the heart uses up to 8% of the total energy expenditure. Due to the relatively low adenosine triphosphate (ATP) storage capacity, the heart's work is dependent on its production. This is possible due to the metabolic flexibility of the heart, which allows it to use numerous substrates as a source of energy. Under normal conditions, a healthy heart obtains approximately 95% of its ATP by oxidative phosphorylation in the mitochondria. The primary source of energy is fatty acid oxidation, the rest of the energy comes from the oxidation of pyruvate. A failed heart is characterised by a disturbance in these proportions, with the contribution of individual components as a source of energy depending on the aetiology and stage of heart failure. A unique form of cardiac dysfunction is sepsis-induced cardiomyopathy, characterised by a significant reduction in energy production and impairment of cardiac oxidation of both fatty acids and glucose. Metabolic disorders appear to contribute to the pathogenesis of cardiac dysfunction and therefore are a promising target for future therapies. However, as many aspects of the metabolism of the failing heart remain unexplained, this issue requires further research.

Entities:  

Keywords:  cardiac metabolism; heart failure; intensive care; metabolic remodelling; sepsis; sepsis-induced cardiomyopathy

Year:  2021        PMID: 34300048     DOI: 10.3390/ijerph18147598

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  6 in total

Review 1.  Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy.

Authors:  Oluwabukunmi Modupe Salami; Olive Habimana; Jin-Fu Peng; Guang-Hui Yi
Journal:  Cardiovasc Drugs Ther       Date:  2022-06-15       Impact factor: 3.727

2.  Protein Phosphatase 2A Improves Cardiac Functional Response to Ischemia and Sepsis.

Authors:  Ulrich Gergs; Tina Jahn; Nico Schulz; Claudia Großmann; Uwe Rueckschloss; Uta Demus; Igor B Buchwalow; Joachim Neumann
Journal:  Int J Mol Sci       Date:  2022-04-23       Impact factor: 6.208

3.  Identification of Crucial Genes and Infiltrating Immune Cells Underlying Sepsis-Induced Cardiomyopathy via Weighted Gene Co-Expression Network Analysis.

Authors:  Juexing Li; Lei Zhou; Zhenhua Li; Shangneng Yang; Liangyue Tang; Hui Gong
Journal:  Front Genet       Date:  2021-12-24       Impact factor: 4.599

4.  Ketone Body β-Hydroxybutyrate Prevents Myocardial Oxidative Stress in Septic Cardiomyopathy.

Authors:  Liwei Ji; Qinqin He; Yinghai Liu; Yan Deng; Maodi Xie; Kaiteng Luo; Xintian Cai; Yunxia Zuo; Wei Wu; Qian Li; Ronghua Zhou; Tao Li
Journal:  Oxid Med Cell Longev       Date:  2022-03-18       Impact factor: 6.543

5.  Analysis of metabolic disturbances attributable to sepsis-induced myocardial dysfunction using metabolomics and transcriptomics techniques.

Authors:  Xiaonan Jia; Yahui Peng; Xiaohui Ma; Xiaowei Liu; Kaijiang Yu; Changsong Wang
Journal:  Front Mol Biosci       Date:  2022-08-15

6.  Clemastine protects against sepsis-induced myocardial injury in vivo and in vitro.

Authors:  Xiaowan Wang; Di Xie; Hui Dai; Jiawei Ye; Yuqi Liu; Aihua Fei
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.